Skip to main content
. 2019 Apr 23;16:675–685. doi: 10.1016/j.omtn.2019.04.017

Table 1.

Characteristics of Patients with NSCLC

Variable Number of Patients (%)
p
miR150 Low (n = 47) miR150 High (n = 64)
Gender 0.80
 Male 35 (74.47) 49 (76.56)
 Female 12 (25.53) 15 (23.44)

Age 0.77
 ≤60 27 (57.45) 35 (54.69)
 >60 20 (42.55) 29 (45.31)

Smoking 0.48
 Yes 27 (57.45) 41 (64.06)
 No 20 (42.55) 23 (35.94)

Histology 0.48
 Adenocarcinoma 23 (48.94) 29 (45.31)
 Squamous cell carcinoma 22 (46.80) 29 (45.31)
 Bronchioloalveolar carcinoma 0 (0.00) 1 (1.56)
 Large-cell carcinoma 0 (0.00) 2 (3.13)
 Carcinoid 0 (0.00) 2 (3.13)
 Other 2 (4.26) 1(1.56)

T status 0.49
 T1 7 (14.89) 12 (18.75)
 T2 22 (46.81) 34 (53.12)
 T3 13 (27.66) 10 (15.63)
 T4 5 (10.64) 8 (12.50)

N status 0.01
 N0 20 (42.55) 48(75.00)
 N1 15 (29.79) 9 (15.63)
 N2 11 (25.53) 7 (9.37)
 N3 1 (2.13) 0 (0.00)

M status 0.04
 M0 44 (87.23) 64 (95.31)
 M1 3 (2.13) 0 (0.00)